Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Bmc Cancer
Sigurdson, Alice J AJ; Hauptmann, Michael M; Chatterjee, Nilanjan N; Alexander, Bruce H BH; Doody, Michele Morin MM; Rutter, Joni L JL; Struewing, Jeffery P JP